Qualigen Therapeutics Inc (QLGN)

Finanzdaten der Qualigen Therapeutics Inc-Aktie (QLGN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	122.57% -0.3673	1.627	1.6072	1.3899	1.4411
Operating Expenses	46.34% 2.7784	5.1782	5.2999	10.04	5.824
Benefits Costs and Expenses	44.56% 2.8678	5.1729	5.8782	10.19	5.4969
Costs And Expenses	44.56% 2.8678	5.1729	5.8782	10.19	5.4969
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	21.76% -2.7784	-3.5511	-3.6928	-8.6485	-4.3829
Net Interest Income/Expense	2.69% -0.3673	-0.3774	-0.5442	-0.0424	0.00463
Nonoperating Income/Loss	8,788% -0.4567	0.00526	-0.5783	-0.1542	0.3271
Income/Loss From Continuing Operations Before Tax	8.77% -3.235	-3.5459	-4.271	-8.8027	-4.0559
Income/Loss From Continuing Operations After Tax	7.77% -3.235	-3.5077	-4.1072	-8.5376	-4.0559
Income/Loss From Discontinued Operations, Net Of Tax	-0.46	-	-	-	-
Net Income/Loss	5.34% -3.6951	-3.5077	-4.1072	-8.5315	-4.0559
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	11.40% -0.0385	-0.0435	-	-2.1592	-0.2308
Basic Average Shares	0.00% 5.0525	5.0525	4.9591	-33.31	39.44
Diluted Average Shares	0.00% 5.0525	5.0525	-0.0464	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-